Search research articles
Contact Us
Filters
Showing results (231-240 of 6,821) with videos related to
Page
of 683
Sort By:
Nature Reviews. Drug Discovery
|
December 29, 2017
Can innate immune system targets turn up the heat on 'cold' tumours?
Asher Mullard
Nature Reviews. Drug Discovery
|
January 14, 2022
FDA approves first-in-class TSLP-targeted antibody for severe asthma
Asher Mullard
Nature Reviews. Drug Discovery
|
January 14, 2022
New naming scheme for antibodies drops the -mab stem
Asher Mullard
Nature Reviews. Drug Discovery
|
January 14, 2021
Sarepta's DMD gene therapy falls flat
Asher Mullard
Epidemics
|
March 27, 2017
Forecasting Ebola with a regression transmission model
Jason Asher
Nature Reviews. Drug Discovery
|
March 31, 2017
PRIME time at the EMA
Asher Mullard
Nature Reviews. Drug Discovery
|
April 1, 2017
Bracing for the biosimilar wave
Asher Mullard
Nature Reviews. Drug Discovery
|
August 2, 2019
Anti-CD3 antibody charts out a type 1 diabetes comeback
Asher Mullard
Nature Reviews. Drug Discovery
|
October 10, 2022
FDA advisory committee votes for approval of first microbiome-based drug, despite data problems
Asher Mullard
Nature Reviews. Drug Discovery
|
February 12, 2021
FDA approves fourth CAR-T cell therapy
Asher Mullard
Page
of 683
Search research articles
Search
Showing results (231-240 of 6,821) with videos related to
Sort By:
Page
of 683
Nature Reviews. Drug Discovery
|
December 29, 2017
Can innate immune system targets turn up the heat on 'cold' tumours?
Asher Mullard
Nature Reviews. Drug Discovery
|
January 14, 2022
FDA approves first-in-class TSLP-targeted antibody for severe asthma
Asher Mullard
Nature Reviews. Drug Discovery
|
January 14, 2022
New naming scheme for antibodies drops the -mab stem
Asher Mullard
Nature Reviews. Drug Discovery
|
January 14, 2021
Sarepta's DMD gene therapy falls flat
Asher Mullard
Epidemics
|
March 27, 2017
Forecasting Ebola with a regression transmission model
Jason Asher
Nature Reviews. Drug Discovery
|
March 31, 2017
PRIME time at the EMA
Asher Mullard
Nature Reviews. Drug Discovery
|
April 1, 2017
Bracing for the biosimilar wave
Asher Mullard
Nature Reviews. Drug Discovery
|
August 2, 2019
Anti-CD3 antibody charts out a type 1 diabetes comeback
Asher Mullard
Nature Reviews. Drug Discovery
|
October 10, 2022
FDA advisory committee votes for approval of first microbiome-based drug, despite data problems
Asher Mullard
Nature Reviews. Drug Discovery
|
February 12, 2021
FDA approves fourth CAR-T cell therapy
Asher Mullard
Page
of 683